{"name":"Wyeth is now a wholly owned subsidiary of Pfizer","slug":"wyeth-is-now-a-wholly-owned-subsidiary-of-pfizer","ticker":"","exchange":"","domain":"wyethisnowawhollyownedsubsidiaryofpfizer.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-06-12","label":"Isovorin Phase 3 readout (Metastatic Esophageal Squamous Cell Carcinoma)","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-30","label":"Isovorin Phase 3 readout (Hepatocellular Carcinoma, Liver Transplantation)","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-02-01","label":"Isovorin Phase 3 readout (Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC))","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-12-31","label":"Isovorin Phase 3 readout (Colorectal Neoplasms, Chemotherapy Effect)","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-09-30","label":"Isovorin Phase 3 readout (Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer)","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-06-01","label":"Isovorin Phase 3 readout (Colorectal Cancer)","drug":"Isovorin","drugSlug":"isovorin","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":32,"colorKey":"oncology","drugs":[{"name":"Rapamune® (Sirolimus)","genericName":"Rapamune® (Sirolimus)","slug":"rapamune-sirolimus","indication":"Prophylaxis of organ rejection in patients receiving renal transplants","status":"marketed"},{"name":"rhIL-11","genericName":"rhIL-11","slug":"rhil-11","indication":"Other","status":"marketed"},{"name":"7vPnC","genericName":"7vPnC","slug":"7vpnc","indication":"Prevention of meningococcal disease caused by serogroups B and Y in individuals 10 through 25 years of age","status":"phase_3"},{"name":"AS-101","genericName":"AS-101","slug":"as-101","indication":"Other","status":"phase_1"},{"name":"BDDrFVII","genericName":"BDDrFVII","slug":"bddrfvii","indication":"Other","status":"phase_1"},{"name":"Prevenar","genericName":"Prevenar","slug":"prevenar","indication":"Other","status":"marketed"},{"name":"ibuprofen Formulation 2","genericName":"ibuprofen Formulation 2","slug":"ibuprofen-formulation-2","indication":"Other","status":"marketed"},{"name":"7-valent pneumococcal conjugate vaccine","genericName":"7-valent pneumococcal conjugate vaccine","slug":"7-valent-pneumococcal-conjugate-vaccine","indication":"Other","status":"marketed"},{"name":"Advante","genericName":"Advante","slug":"advante","indication":"Other","status":"marketed"},{"name":"Bazedoxifene Acetate (TSE-424)","genericName":"Bazedoxifene Acetate (TSE-424)","slug":"bazedoxifene-acetate-tse-424","indication":"Prevention of postmenopausal osteoporosis","status":"phase_3"},{"name":"Bazedoxifene and conjugated estrogens","genericName":"Bazedoxifene and conjugated estrogens","slug":"bazedoxifene-and-conjugated-estrogens","indication":"Moderate to severe vasomotor symptoms associated with menopause","status":"phase_2"},{"name":"HCV 796","genericName":"HCV 796","slug":"hcv-796","indication":"Other","status":"phase_2"},{"name":"InductOs","genericName":"InductOs","slug":"inductos","indication":"Other","status":"marketed"},{"name":"Isovorin","genericName":"Isovorin","slug":"isovorin","indication":"Other","status":"discontinued"},{"name":"Meningococcal C","genericName":"Meningococcal C","slug":"meningococcal-c","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup C","status":"marketed"},{"name":"Methotrexate plus ENBREL or ENBREL alone","genericName":"Methotrexate plus ENBREL or ENBREL alone","slug":"methotrexate-plus-enbrel-or-enbrel-alone","indication":"Other","status":"marketed"},{"name":"Methotrexate plus ERB-041 for 12 weeks","genericName":"Methotrexate plus ERB-041 for 12 weeks","slug":"methotrexate-plus-erb-041-for-12-weeks","indication":"Other","status":"phase_2"},{"name":"Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide","genericName":"Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide","slug":"methotrexate-sulfasalazine-hydroxychloroquine-leflunomide","indication":"Other","status":"marketed"},{"name":"PVC (twice weekly)","genericName":"PVC (twice weekly)","slug":"pvc-twice-weekly","indication":"Prevention of recurrent symptomatic supraventricular tachycardia","status":"phase_3"},{"name":"Pantoprazole for approximately 9 weeks","genericName":"Pantoprazole for approximately 9 weeks","slug":"pantoprazole-for-approximately-9-weeks","indication":"Gastroesophageal reflux disease (GERD)","status":"phase_3"},{"name":"Pentavac","genericName":"Pentavac","slug":"pentavac","indication":"Other","status":"phase_3"},{"name":"Perioperative Corticosteroids","genericName":"Perioperative Corticosteroids","slug":"perioperative-corticosteroids","indication":"Perioperative anti-inflammatory prophylaxis in major surgery","status":"marketed"},{"name":"Recombinant Factor IX Coagulation","genericName":"Recombinant Factor IX Coagulation","slug":"recombinant-factor-ix-coagulation","indication":"Other","status":"marketed"},{"name":"TMI-005","genericName":"TMI-005","slug":"tmi-005","indication":"Other","status":"phase_2"},{"name":"Tibolone (Livial)","genericName":"Tibolone (Livial)","slug":"tibolone-livial","indication":"Vasomotor symptoms of menopause (hot flushes, night sweats)","status":"marketed"},{"name":"Totelle®","genericName":"Totelle®","slug":"totelle","indication":"Other","status":"marketed"},{"name":"bazedoxifene BZA-20","genericName":"bazedoxifene BZA-20","slug":"bazedoxifene-bza-20","indication":"Treatment and prevention of postmenopausal osteoporosis","status":"phase_3"},{"name":"ceftriaxone plus metronidazole","genericName":"ceftriaxone plus metronidazole","slug":"ceftriaxone-plus-metronidazole","indication":"Other","status":"marketed"},{"name":"glycopeptide","genericName":"glycopeptide","slug":"glycopeptide","indication":"Other","status":"phase_2"},{"name":"ibuprofen Formulation 1","genericName":"ibuprofen Formulation 1","slug":"ibuprofen-formulation-1","indication":"Other","status":"marketed"},{"name":"meningococcal B rLP2086 vaccine candidate","genericName":"meningococcal B rLP2086 vaccine candidate","slug":"meningococcal-b-rlp2086-vaccine-candidate","indication":"Other","status":"phase_1"},{"name":"pneumococcus conjugate vaccine","genericName":"pneumococcus conjugate vaccine","slug":"pneumococcus-conjugate-vaccine","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"neuroscience","drugs":[{"name":"etanercept (EnbrelTM)","genericName":"etanercept (EnbrelTM)","slug":"etanercept-enbreltm","indication":"Rheumatoid arthritis","status":"marketed"},{"name":"Cyclosporin or tacrolimus","genericName":"Cyclosporin or tacrolimus","slug":"cyclosporin-or-tacrolimus","indication":"Organ transplant rejection prophylaxis (renal, cardiac, hepatic)","status":"phase_3"},{"name":"Etanercept + Methotrexate","genericName":"Etanercept + Methotrexate","slug":"etanercept-methotrexate","indication":"Rheumatoid arthritis (moderate to severe, active disease)","status":"marketed"},{"name":"Neoral® (Cyclosporine)","genericName":"Neoral® (Cyclosporine)","slug":"neoral-cyclosporine","indication":"Organ transplant rejection prophylaxis (kidney, heart, liver, pancreas)","status":"marketed"},{"name":"sulphasalazine (SSZ)","genericName":"sulphasalazine (SSZ)","slug":"sulphasalazine-ssz","indication":"Ulcerative colitis","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"respiratory","drugs":[{"name":"DVS-233 SR","genericName":"DVS-233 SR","slug":"dvs-233-sr","indication":"Major depressive disorder","status":"phase_3"},{"name":"Effexor","genericName":"Effexor","slug":"effexor","indication":"Generalized anxiety disorder","status":"marketed"},{"name":"Effexor® (Venlafaxine)","genericName":"Effexor® (Venlafaxine)","slug":"effexor-venlafaxine","indication":"Major depressive disorder","status":"marketed"},{"name":"bifeprunox, olanzapine","genericName":"bifeprunox, olanzapine","slug":"bifeprunox-olanzapine","indication":"Schizophrenia","status":"phase_3"},{"name":"desvenlafaxine SR","genericName":"desvenlafaxine SR","slug":"desvenlafaxine-sr","indication":"Major depressive disorder","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"EKB-569","genericName":"EKB-569","slug":"ekb-569","indication":"Non-small cell lung cancer","status":"phase_2"},{"name":"Sirolimus (Rapamune®)","genericName":"Sirolimus (Rapamune®)","slug":"sirolimus-rapamune","indication":"Prophylaxis of organ rejection in patients receiving renal transplants","status":"phase_3"},{"name":"ATRA plus 6-MP and MTX","genericName":"ATRA plus 6-MP and MTX","slug":"atra-plus-6-mp-and-mtx","indication":"Acute promyelocytic leukemia (APL)","status":"phase_3"},{"name":"Rapamune","genericName":"Rapamune","slug":"rapamune","indication":"Gorham's disease","status":"marketed"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"ReFacto","genericName":"ReFacto","slug":"refacto","indication":"Hemophilia A (congenital Factor VIII deficiency) — prevention and treatment of bleeding episodes","status":"marketed"},{"name":"rFIX","genericName":"rFIX","slug":"rfix","indication":"Hemophilia B (Factor IX deficiency) — prevention and treatment of bleeding episodes","status":"phase_3"},{"name":"Factor IX recovery","genericName":"Factor IX recovery","slug":"factor-ix-recovery","indication":"Hemophilia B (Factor IX deficiency)","status":"marketed"},{"name":"rFIX-R","genericName":"rFIX-R","slug":"rfix-r","indication":"Treatment of bleeding episodes in patients with hemophilia B","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"infectious","drugs":[{"name":"23vPS","genericName":"23vPS","slug":"23vps","indication":"Prevention of invasive pneumococcal disease in adults and children ≥2 years of age","status":"phase_3"},{"name":"Prevenar and Meningitec","genericName":"Prevenar and Meningitec","slug":"prevenar-and-meningitec","indication":"Prevention of invasive pneumococcal disease caused by 13 serotypes of Streptococcus pneumoniae (Prevenar)","status":"marketed"},{"name":"Third generation cephalosporins","genericName":"Third generation cephalosporins","slug":"third-generation-cephalosporins","indication":"Bacterial infections caused by susceptible gram-positive and gram-negative organisms","status":"marketed"},{"name":"ceftriaxone sodium + metronidazole","genericName":"ceftriaxone sodium + metronidazole","slug":"ceftriaxone-sodium-metronidazole","indication":"Intra-abdominal infections (including peritonitis and appendicitis)","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"Levonorgestrel/Ethinyl Estradiol","genericName":"Levonorgestrel/Ethinyl Estradiol","slug":"levonorgestrel-ethinyl-estradiol","indication":"Contraception (prevention of pregnancy)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"Sirolimus+MMF or MPS or AZA+Steroid","genericName":"Sirolimus+MMF or MPS or AZA+Steroid","slug":"sirolimus-mmf-or-mps-or-aza-steroid","indication":"Prevention of organ rejection in solid organ transplantation (kidney, heart, liver)","status":"marketed"}]}],"pipeline":[{"name":"Rapamune® (Sirolimus)","genericName":"Rapamune® (Sirolimus)","slug":"rapamune-sirolimus","phase":"marketed","mechanism":"Sirolimus inhibits mTOR (mammalian target of rapamycin), a key signaling protein that controls cell growth and proliferation, thereby suppressing immune cell activation and reducing organ rejection.","indications":["Prophylaxis of organ rejection in patients receiving renal transplants","Lymphangioleiomyomatosis (LAM)"],"catalyst":""},{"name":"rhIL-11","genericName":"rhIL-11","slug":"rhil-11","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"7vPnC","genericName":"7vPnC","slug":"7vpnc","phase":"phase_3","mechanism":"7vPnC is a vaccine that protects against meningococcal disease caused by serogroups B and Y.","indications":["Prevention of meningococcal disease caused by serogroups B and Y in individuals 10 through 25 years of age"],"catalyst":""},{"name":"AS-101","genericName":"AS-101","slug":"as-101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BDDrFVII","genericName":"BDDrFVII","slug":"bddrfvii","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EKB-569","genericName":"EKB-569","slug":"ekb-569","phase":"phase_2","mechanism":"EKB-569 is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.","indications":["Non-small cell lung cancer"],"catalyst":""},{"name":"Prevenar","genericName":"Prevenar","slug":"prevenar","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ReFacto","genericName":"ReFacto","slug":"refacto","phase":"marketed","mechanism":"ReFacto is a recombinant antihemophilic factor (Factor VIII) that replaces deficient or dysfunctional clotting factor VIII to restore blood coagulation in hemophilia A patients.","indications":["Hemophilia A (congenital Factor VIII deficiency) — prevention and treatment of bleeding episodes","Perioperative management in hemophilia A patients"],"catalyst":""},{"name":"Sirolimus (Rapamune®)","genericName":"Sirolimus (Rapamune®)","slug":"sirolimus-rapamune","phase":"phase_3","mechanism":"Sirolimus inhibits mTOR (mammalian target of rapamycin), a key signaling protein that controls cell growth and proliferation.","indications":["Prophylaxis of organ rejection in patients receiving renal transplants","Lymphangioleiomyomatosis (LAM)","Tuberous sclerosis complex (TSC)-associated tumors"],"catalyst":""},{"name":"etanercept (EnbrelTM)","genericName":"etanercept (EnbrelTM)","slug":"etanercept-enbreltm","phase":"marketed","mechanism":"Etanercept is a TNF receptor fusion protein that binds and neutralizes tumor necrosis factor (TNF), a key inflammatory cytokine driving immune-mediated diseases.","indications":["Rheumatoid arthritis","Psoriatic arthritis","Ankylosing spondylitis","Polyarticular juvenile idiopathic arthritis","Plaque psoriasis"],"catalyst":""},{"name":"ibuprofen Formulation 2","genericName":"ibuprofen Formulation 2","slug":"ibuprofen-formulation-2","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"rFIX","genericName":"rFIX","slug":"rfix","phase":"phase_3","mechanism":"rFIX is a recombinant human coagulation factor IX that replaces deficient or dysfunctional Factor IX to restore blood clotting ability in hemophilia B patients.","indications":["Hemophilia B (Factor IX deficiency) — prevention and treatment of bleeding episodes","Hemophilia B — perioperative management"],"catalyst":""},{"name":"23vPS","genericName":"23vPS","slug":"23vps","phase":"phase_3","mechanism":"23vPS is a 23-valent pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.","indications":["Prevention of invasive pneumococcal disease in adults and children ≥2 years of age","Prevention of pneumococcal pneumonia"],"catalyst":""},{"name":"7-valent pneumococcal conjugate vaccine","genericName":"7-valent pneumococcal conjugate vaccine","slug":"7-valent-pneumococcal-conjugate-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ATRA plus 6-MP and MTX","genericName":"ATRA plus 6-MP and MTX","slug":"atra-plus-6-mp-and-mtx","phase":"phase_3","mechanism":"This combination uses ATRA to differentiate leukemic cells while 6-MP and MTX provide cytotoxic chemotherapy to eliminate rapidly dividing cancer cells.","indications":["Acute promyelocytic leukemia (APL)","Acute myeloid leukemia (AML)"],"catalyst":""},{"name":"Advante","genericName":"Advante","slug":"advante","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bazedoxifene Acetate (TSE-424)","genericName":"Bazedoxifene Acetate (TSE-424)","slug":"bazedoxifene-acetate-tse-424","phase":"phase_3","mechanism":"Bazedoxifene is a selective estrogen receptor modulator (SERM) that acts as an estrogen agonist in bone and lipid metabolism while functioning as an antagonist in breast and uterine tissue.","indications":["Prevention of postmenopausal osteoporosis","Treatment of postmenopausal osteoporosis"],"catalyst":""},{"name":"Bazedoxifene and conjugated estrogens","genericName":"Bazedoxifene and conjugated estrogens","slug":"bazedoxifene-and-conjugated-estrogens","phase":"phase_2","mechanism":"Bazedoxifene is a selective estrogen receptor modulator (SERM) that provides estrogen-like benefits in bone and lipid metabolism while blocking estrogen effects in breast tissue, combined with conjugated estrogens for menopausal symptom relief.","indications":["Moderate to severe vasomotor symptoms associated with menopause","Prevention of postmenopausal osteoporosis"],"catalyst":""},{"name":"Cyclosporin or tacrolimus","genericName":"Cyclosporin or tacrolimus","slug":"cyclosporin-or-tacrolimus","phase":"phase_3","mechanism":"Cyclosporin and tacrolimus are calcineurin inhibitors that suppress T-cell activation by blocking the transcription of pro-inflammatory cytokines.","indications":["Organ transplant rejection prophylaxis (renal, cardiac, hepatic)","Autoimmune diseases (atopic dermatitis, psoriasis, rheumatoid arthritis)"],"catalyst":""},{"name":"DVS-233 SR","genericName":"DVS-233 SR","slug":"dvs-233-sr","phase":"phase_3","mechanism":"DVS-233 SR is a sustained-release formulation of venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases synaptic levels of serotonin and norepinephrine by blocking their reuptake.","indications":["Major depressive disorder","Generalized anxiety disorder","Social anxiety disorder","Panic disorder"],"catalyst":""},{"name":"Effexor","genericName":"Effexor","slug":"effexor","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C","indications":["Generalized anxiety disorder","Major depressive disorder","Panic disorder","Social phobia"],"catalyst":""},{"name":"Effexor® (Venlafaxine)","genericName":"Effexor® (Venlafaxine)","slug":"effexor-venlafaxine","phase":"marketed","mechanism":"Venlafaxine inhibits the reuptake of serotonin and norepinephrine in the central nervous system, increasing their availability at synaptic sites.","indications":["Major depressive disorder","Generalized anxiety disorder","Social anxiety disorder","Panic disorder","Vasomotor symptoms associated with menopause"],"catalyst":""},{"name":"Etanercept + Methotrexate","genericName":"Etanercept + Methotrexate","slug":"etanercept-methotrexate","phase":"marketed","mechanism":"Etanercept blocks tumor necrosis factor (TNF) to reduce inflammation, while methotrexate suppresses immune cell proliferation; together they synergistically reduce joint inflammation and slow disease progression in rheumatoid arthritis.","indications":["Rheumatoid arthritis (moderate to severe, active disease)","Polyarticular juvenile idiopathic arthritis"],"catalyst":""},{"name":"Factor IX recovery","genericName":"Factor IX recovery","slug":"factor-ix-recovery","phase":"marketed","mechanism":"Factor IX recovery refers to the measurement of how much functional Factor IX (a blood clotting protein) is present in the bloodstream after administration of a Factor IX replacement product.","indications":["Hemophilia B (Factor IX deficiency)","Prevention and treatment of bleeding episodes in Factor IX-deficient patients"],"catalyst":""},{"name":"HCV 796","genericName":"HCV 796","slug":"hcv-796","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"InductOs","genericName":"InductOs","slug":"inductos","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Isovorin","genericName":"Isovorin","slug":"isovorin","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Levonorgestrel/Ethinyl Estradiol","genericName":"Levonorgestrel/Ethinyl Estradiol","slug":"levonorgestrel-ethinyl-estradiol","phase":"marketed","mechanism":"This combination oral contraceptive suppresses ovulation by inhibiting the luteinizing hormone surge through progestin and estrogen feedback on the hypothalamic-pituitary axis.","indications":["Contraception (prevention of pregnancy)","Regulation of menstrual cycle","Treatment of acne vulgaris","Treatment of polycystic ovary syndrome (PCOS) symptoms"],"catalyst":""},{"name":"Meningococcal C","genericName":"Meningococcal C","slug":"meningococcal-c","phase":"marketed","mechanism":"Meningococcal C conjugate vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C polysaccharide capsule.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup C"],"catalyst":""},{"name":"Methotrexate plus ENBREL or ENBREL alone","genericName":"Methotrexate plus ENBREL or ENBREL alone","slug":"methotrexate-plus-enbrel-or-enbrel-alone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methotrexate plus ERB-041 for 12 weeks","genericName":"Methotrexate plus ERB-041 for 12 weeks","slug":"methotrexate-plus-erb-041-for-12-weeks","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide","genericName":"Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide","slug":"methotrexate-sulfasalazine-hydroxychloroquine-leflunomide","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Neoral® (Cyclosporine)","genericName":"Neoral® (Cyclosporine)","slug":"neoral-cyclosporine","phase":"marketed","mechanism":"Cyclosporine inhibits T-cell activation by binding to cyclophilin and blocking calcineurin-mediated transcription of interleukin-2 and other cytokines.","indications":["Organ transplant rejection prophylaxis (kidney, heart, liver, pancreas)","Severe active rheumatoid arthritis","Severe psoriasis","Nephrotic syndrome (minimal change disease)","Severe atopic dermatitis"],"catalyst":""},{"name":"PVC (twice weekly)","genericName":"PVC (twice weekly)","slug":"pvc-twice-weekly","phase":"phase_3","mechanism":"PVC works by blocking the action of certain electrical signals in the heart, helping to regulate its rhythm.","indications":["Prevention of recurrent symptomatic supraventricular tachycardia"],"catalyst":""},{"name":"Pantoprazole for approximately 9 weeks","genericName":"Pantoprazole for approximately 9 weeks","slug":"pantoprazole-for-approximately-9-weeks","phase":"phase_3","mechanism":"Pantoprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.","indications":["Gastroesophageal reflux disease (GERD)","Peptic ulcer disease","Zollinger-Ellison syndrome","Acid-related gastrointestinal conditions"],"catalyst":""},{"name":"Pentavac","genericName":"Pentavac","slug":"pentavac","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Perioperative Corticosteroids","genericName":"Perioperative Corticosteroids","slug":"perioperative-corticosteroids","phase":"marketed","mechanism":"Corticosteroids suppress the inflammatory and immune response by binding to glucocorticoid receptors, reducing the production of pro-inflammatory cytokines and mediators.","indications":["Perioperative anti-inflammatory prophylaxis in major surgery","Prevention of postoperative complications including systemic inflammatory response and organ dysfunction"],"catalyst":""},{"name":"Prevenar and Meningitec","genericName":"Prevenar and Meningitec","slug":"prevenar-and-meningitec","phase":"marketed","mechanism":"These are conjugate vaccines that stimulate the immune system to produce antibodies against specific bacterial pathogens by linking polysaccharide antigens to protein carriers.","indications":["Prevention of invasive pneumococcal disease caused by 13 serotypes of Streptococcus pneumoniae (Prevenar)","Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup C (Meningitec)"],"catalyst":""},{"name":"Rapamune","genericName":"Rapamune","slug":"rapamune","phase":"marketed","mechanism":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","indications":["Gorham's disease","Lymphangiectasis","Lymphangioma","Lymphangiomatosis","Prevention of Kidney Transplant Rejection"],"catalyst":""},{"name":"Recombinant Factor IX Coagulation","genericName":"Recombinant Factor IX Coagulation","slug":"recombinant-factor-ix-coagulation","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sirolimus+MMF or MPS or AZA+Steroid","genericName":"Sirolimus+MMF or MPS or AZA+Steroid","slug":"sirolimus-mmf-or-mps-or-aza-steroid","phase":"marketed","mechanism":"This combination regimen suppresses T-cell proliferation and antibody production through mTOR inhibition (sirolimus) and inosine monophosphate dehydrogenase inhibition (MMF/MPS/AZA), used to prevent organ rejection.","indications":["Prevention of organ rejection in solid organ transplantation (kidney, heart, liver)","Chronic rejection prevention in transplant recipients"],"catalyst":""},{"name":"TMI-005","genericName":"TMI-005","slug":"tmi-005","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Third generation cephalosporins","genericName":"Third generation cephalosporins","slug":"third-generation-cephalosporins","phase":"marketed","mechanism":"Third-generation cephalosporins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan.","indications":["Bacterial infections caused by susceptible gram-positive and gram-negative organisms","Respiratory tract infections","Urinary tract infections","Intra-abdominal infections","Meningitis"],"catalyst":""},{"name":"Tibolone (Livial)","genericName":"Tibolone (Livial)","slug":"tibolone-livial","phase":"marketed","mechanism":"Tibolone is a synthetic steroid that acts as a selective tissue estrogenic activity regulator (STEAR), providing estrogenic, progestagenic, and androgenic effects to alleviate menopausal symptoms.","indications":["Vasomotor symptoms of menopause (hot flushes, night sweats)","Mood disturbances associated with menopause","Vaginal atrophy and sexual dysfunction in postmenopausal women","Bone loss prevention in postmenopausal women"],"catalyst":""},{"name":"Totelle®","genericName":"Totelle®","slug":"totelle","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"bazedoxifene BZA-20","genericName":"bazedoxifene BZA-20","slug":"bazedoxifene-bza-20","phase":"phase_3","mechanism":"Bazedoxifene acts as a selective estrogen receptor modulator (SERM) with agonist activity on the estrogen receptor beta and antagonist activity on the estrogen receptor alpha.","indications":["Treatment and prevention of postmenopausal osteoporosis"],"catalyst":""},{"name":"bifeprunox, olanzapine","genericName":"bifeprunox, olanzapine","slug":"bifeprunox-olanzapine","phase":"phase_3","mechanism":"Bifeprunox is a selective dopamine D2 receptor antagonist and serotonin 5-HT2A receptor antagonist, and olanzapine is a serotonin 5-HT2A receptor antagonist and a dopamine D2 receptor antagonist.","indications":["Schizophrenia","Bipolar disorder"],"catalyst":""},{"name":"ceftriaxone plus metronidazole","genericName":"ceftriaxone plus metronidazole","slug":"ceftriaxone-plus-metronidazole","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ceftriaxone sodium + metronidazole","genericName":"ceftriaxone sodium + metronidazole","slug":"ceftriaxone-sodium-metronidazole","phase":"marketed","mechanism":"This combination uses a third-generation cephalosporin to inhibit bacterial cell wall synthesis and a nitroimidazole to disrupt anaerobic bacterial DNA, providing broad-spectrum coverage against aerobic gram-negative, gram-positive, and anaerobic organisms.","indications":["Intra-abdominal infections (including peritonitis and appendicitis)","Gynecological infections","Anaerobic bacterial infections with mixed aerobic-anaerobic flora","Prophylaxis in abdominal and gynecological surgery"],"catalyst":""},{"name":"desvenlafaxine SR","genericName":"desvenlafaxine SR","slug":"desvenlafaxine-sr","phase":"phase_3","mechanism":"Desvenlafaxine SR is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.","indications":["Major depressive disorder","Generalized anxiety disorder"],"catalyst":""},{"name":"glycopeptide","genericName":"glycopeptide","slug":"glycopeptide","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ibuprofen Formulation 1","genericName":"ibuprofen Formulation 1","slug":"ibuprofen-formulation-1","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"meningococcal B rLP2086 vaccine candidate","genericName":"meningococcal B rLP2086 vaccine candidate","slug":"meningococcal-b-rlp2086-vaccine-candidate","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"pneumococcus conjugate vaccine","genericName":"pneumococcus conjugate vaccine","slug":"pneumococcus-conjugate-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"rFIX-R","genericName":"rFIX-R","slug":"rfix-r","phase":"phase_3","mechanism":"rFIX-R is a recombinant coagulation factor IX used to treat bleeding episodes in patients with hemophilia B.","indications":["Treatment of bleeding episodes in patients with hemophilia B","Prevention of bleeding in patients with hemophilia B undergoing surgery"],"catalyst":""},{"name":"sulphasalazine (SSZ)","genericName":"sulphasalazine (SSZ)","slug":"sulphasalazine-ssz","phase":"marketed","mechanism":"Sulphasalazine is a prodrug that is cleaved by colonic bacteria into 5-aminosalicylic acid and sulfapyridine, with the 5-ASA component exerting local anti-inflammatory effects in the colon.","indications":["Ulcerative colitis","Crohn's disease","Rheumatoid arthritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiPkFVX3lxTE10d0ZMTWRLaFR1Wm43LWlFbC1SXzNRLUtfN1psRGpSUDNVTTRySTdZaXVuMmlFelFTMGpOMW9B?oc=5","date":"2025-10-14","type":"pipeline","source":"Ad Age","summary":"Pfizer—ad spending, facts and profile - Ad Age","headline":"Pfizer—ad spending, facts and profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPVDNNVk42eEljRmRNQ09aOTFldVpGc2wwNXhuLXM0YnRlTFkzdFFhTElSNXc2NVo1cmppWWVsWWE1T1U1cmtobkFMeFkzU0dCeGpqYng0S2o0dEx0MmhseEZCZjg4bWM1R3ptNjlUUjVwSnRvWWRyQWktSWFaNldHX0VvdXlOY3pUZHU4d2dUX0xieUs4c1FnMExKWXM4dVE4b1Q4TWhlTGNFbVJFc0dlX3NHNnhPUmd4ZHptbGZncFlpalNYeWc?oc=5","date":"2024-12-23","type":"pipeline","source":"Reuters","summary":"Ex-judge ends lawsuit against law firm Hagens Berman over pharma fee award - Reuters","headline":"Ex-judge ends lawsuit against law firm Hagens Berman over pharma fee award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQQUMyZ040Y00yOVlLcmM0bUZla3hEbXZaWUdQUkpxMk95NUppZmdIX2Z5VTFCdWgyVEFXRDF3bUdfeXpneWl1MTdkOTNPc3ZIVXZlVFFOMS1jSmNtLUFuRUllRUlRMGt4WlJfNWc1Y1Z0NzVXeThhSXVWZ3FIanZvdi1URXFvbndwVzk3RHR3?oc=5","date":"2020-06-22","type":"pipeline","source":"Business Chief","summary":"Pfizer's most expensive acquisitions - Business Chief","headline":"Pfizer's most expensive acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQbkxBcU1uQzFRVVQ0X2p1RWUwOFNnNm9xOFB6WW9PdGw1bUhjMUlMS1J4cFVIb19aRXdsNTc4QTBtVEFiTXJZSkR3bmtETXhWVDFFY0drTWdOTzhNNjUyazhXcHczYkZ1eTdOZV81bWQ4TlJJdDVQUVN5NTFzUFlPeWpaaWVHUkRxRmRYQW04U3lHRlZrVzBjVVZNTlZEcGZkNzdVZV9Td2xGTHEwMDlpX3lZZmdqbnZPMldF?oc=5","date":"2019-01-18","type":"pipeline","source":"Fierce Pharma","summary":"RK Pharma leases part of Pfizer’s Pearl River, New York, campus for manufacturing - Fierce Pharma","headline":"RK Pharma leases part of Pfizer’s Pearl River, New York, campus for manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeUxCLS16bUNjdmNNUzNMdmpWLWFUMkYzX08zakE1c1pnaWZObkNRSG42X2FmUENZMHdOME9JbFV2UEZDMnRrdnVZRXJ3alozN2UxNW1GdW9jZ0dlWDRHYnNTWnpURHgzQ0FWdUwteVdaNUUtWVlERmtFMHo0OVlCYkFXM1lMVW9vZVRJdE5wZTdFQ19JYkFic3RueFFCNjRkUXRwZnNSck1qZw?oc=5","date":"2018-06-12","type":"pipeline","source":"The Journal News | lohud.com","summary":"With new name, Pearl River research campus aims to regain prominence - The Journal News | lohud.com","headline":"With new name, Pearl River research campus aims to regain prominence - The Journal News | lohud.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1OWGRTbDlZNllKM0R1TndvMUU0aEs5SGdRSDg2cUdQNi1wNXZ0bHZTeXgtOFhtRzd5aHNXQ1BHM0l0dXd4NENzWVVVcXpkSzdOM0dqRWV3b01EUjhyd3dFeVU0Ti1pNjVFbE5IRkI0WnVnMEMzUXhR?oc=5","date":"2017-08-20","type":"pipeline","source":"The Journal","summary":"'Oh, that's just the price': €11 difference in cost of same medication in two Dublin pharmacies - The Journal","headline":"'Oh, that's just the price': €11 difference in cost of same medication in two Dublin pharmacies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE03S3pURUlEb0QxdVpvaVRuUjdYNmFWY19Nb1hlM3ZLdWRVdUQzcFhGdEZZcXVrZUh4Q1Q0dVJ4eF91MWtPNGVfQ9IBTkFVX3lxTE0tNlBPWGVJaEF5dnRGY3VkRjdaNEhITWE4WUNDb1pxaVRMZ25xaklyNEIzbE0td1hqOElVZmNpcHB2YUF5dkpUMV8zaU5GZw?oc=5","date":"2017-05-23","type":"deal","source":"dawn.com","summary":"ICI acquires pharma facility, brands for Rs1.9bn - dawn.com","headline":"ICI acquires pharma facility, brands for Rs1.9bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOaDZEOUU3MXNIMUFnZVk2UFlxdUhjaUQ3TEpfMjBQcUhxUHJSX0NSS1J3OUVIM2R4UkZhWlA3TS1rbGJDTUw3Nm9QU2U2RF9hV3BZeVQ1NUtHSmQ3WVhTZ29PNmI2LTF5TXhiZGZrZXh0UzNQcEpKdUc0bERVdmlvVXkzNjZfenJsTjRxcWF0NnBnZWlwaTUtMzV3ZkJkcHZBQ2YtTGJ3?oc=5","date":"2017-03-10","type":"patent","source":"Fierce Pharma","summary":"Pfizer faces first 2017 patent loss as Pristiq generics crash the party - Fierce Pharma","headline":"Pfizer faces first 2017 patent loss as Pristiq generics crash the party","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNR2pNRFJmaWFDM1hpeXBSdVJHUTU3WFRxSWt2d0hXRlJBYTNDM2RqWlRPdU9QaDlZcHdJN09ZNER4WWU4SGxLbVhBb09DOGoxOWZwRVpYTExyVEJEQjc0UXlXYkJpNHJLNDVNZnB3Y21oZlFnaC1YNDhXWktZbzFpRnJlZC02RmFZdlQ2UnFfZzJaVWRpaG0wRkxvZnpFN0hGU09YRE1R?oc=5","date":"2014-08-22","type":"pipeline","source":"CBC","summary":"300 women take on Pfizer over menopause drug ailment - CBC","headline":"300 women take on Pfizer over menopause drug ailment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOQldOZllXVzlYeVVXSkFVZGliS0JzcE95RnJkSnVkXzNaS1d3UXlxSzdEbWVPdXJCbWZIaTVCbWM4M09SVG1YZ2dVRDUyX1laWTVRb2U0SGJXcUNacF92WFZZZVZNdFZxc3Z6T09DdzRWQTF2ZG9MczdKclJzbE9rai1YUzFfWVd2YjVCODdleWFfU3hl?oc=5","date":"2010-07-19","type":"patent","source":"Fierce Pharma","summary":"Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid - Fierce Pharma","headline":"Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNLTRKUHBSbEFPM0ctTXZ1Y3pFTjJJNk4zQndJN3hucmdOWkVyUHUtc1Z5NERTaVMybWdkV3BVV1FQSGxTRDRzYjJuOFZrOWFKR05aLTZKd002SkxITEM3YTlTdF8tX2ZGN1JyRzFGWHFOdEdmTjhDTzV2RUZuOU82aXpQNmV2TFd5WFdETWpB?oc=5","date":"2009-10-16","type":"pipeline","source":"RTTNews","summary":"Pfizer Combines Operations With Wyeth - Update - RTTNews","headline":"Pfizer Combines Operations With Wyeth - Update","sentiment":"neutral"}],"patents":[],"drugCount":56,"phaseCounts":{"marketed":31,"phase_3":15,"phase_1":3,"phase_2":6,"discontinued":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}